Skip to content

Chronic Obstructive Pulmonary Disease (COPD)

COPD research at National Jewish Health is groundbreaking, particularly in the areas of genetics, environmental exposures and clinical trials. Through large-scale genetic studies, we are uncovering the genetic underpinnings of COPD, which could lead to targeted therapies addressing the root causes of the disease. In addition, the institution leads numerous clinical trials aimed at improving COPD management by exploring both pharmacologic and non-pharmacologic interventions. We aim to reduce the burden of this chronic, progressive disease and improve outcomes for patients, particularly those with severe forms of COPD. Here is a look at some of our COPD research efforts:

  • COPDGene Center: We lead the largest NIH-sponsored program examining genetic and clinical changes in the largest COPD patient cohort in the United States. Our COPD Center provides comprehensive care and conducts advanced research, focusing on both clinical and translational research to improve outcomes for patients with COPD.
  • Research Programs: Our renowned researchers conduct innovative research in COPD, including studies on the role of inflammation, oxidative stress, and the genetic, environmental, and immunological factors that contribute to the disease. Research on genetic and epigenetic factors contributing to COPD susceptibility and progression is also a key area of focus. We also explore novel treatment approaches and interventions.
  • Mah Jongg Foundation COPD Accelerator Program
  • Collaborative Efforts: Our researchers work closely with other institutions, pharmaceutical companies and academic centers to advance COPD research. These collaborations leverage a wide range of expertise and resources to accelerate discoveries.
  • Clinical Trials and Innovative Therapies: We conduct clinical trials to test new medications, therapies and devices aimed at improving COPD management. Long-term studies focus on understanding disease progression, identifying biomarkers and evaluating the effectiveness of various treatments over time.
  • COPD Research Advancements
  • Discovery of unique subtypes of COPD through work by COPDGene.
  • Derek Abbott

    Derek Abbott, MD, PhD

  • Rafeul Alam

    Rafeul Alam, MD, PhD

  • Scott Alper

    Scott Alper, PhD

  • Jamie Barr

    Jamie Barr, PhD

  • Hong Wei Chu

    Hong Wei Chu, MD

  • James L. Crooks

    James L. Crooks, PhD, MS

  • Brian J. Day

    Brian J. Day, PhD

  • Hans Dooms

    Hans Dooms, PhD

  • Gregory P. Downey

    Gregory P. Downey, MD, FRCPC

  • Trey Farmer

    Trey Farmer, PhD

  • Evans Fernández

    Evans Fernández, MD, MS

  • Jessica Galant-Swafford

    Jessica Galant-Swafford, MD

  • Fabienne Gally

    Fabienne Gally, PhD

  • Magdalena Maria Gorska

    Magdalena Maria Gorska, MD, PhD

  • Katherine Hisert

    Katherine Hisert, MD, PhD

  • Hua Huang

    Hua Huang, MD, PhD

  • Patrick S. Hume

    Patrick S. Hume, MD, PhD

  • William J. Janssen

    William J. Janssen, MD

  • Rohit K. Katial

    Rohit K. Katial, MD

  • Byung Eui Kim

    Byung Eui Kim, MD, PhD

  • Li Li

    Li Li, MD, PhD

  • Lisa A. Maier

    Lisa A. Maier, MD, MSPH, FCCP, ATSF

  • Mehrnaz Maleki Fischbach

    Mehrnaz Maleki Fischbach, MD

  • Alexandra McCubbrey

    Alexandra McCubbrey, PhD

  • Richard T. Meehan

    Richard T. Meehan, MD, FACP

  • Michael Nevid

    Michael Nevid, MD

  • Cristina Penaranda

    Cristina Penaranda, PhD

  • Lilliana Radoshevich

    Lilliana Radoshevich, PhD

  • Elizabeth F. Redente

    Elizabeth F. Redente, PhD

  • R. Lee Reinhardt

    R. Lee Reinhardt, PhD

  • Gongyi Zhang

    Gongyi Zhang, PhD